

see online retailers
67% of sunscreen: SPF 15-30s have lower concerns
29% of tanning oils have lower concerns




Compact for Safe Cosmetics
|
Animal Testing Policy |


| 5 | UVB hazard/exposure score |
| 4 | UVA hazard/exposure score |
| 4 | sunscreen instability |
*Note that the same active ingredient combination may score differently in two different products depending on the concentration of the ingredients and the mixture of inactive ingredients.
Active ingredient UV |
![]() | ||||||||||||||||||||||||||||||||||||
Product total |
| ||||||||||||||||||||||||||||||||||||
| OCTOCRYLENE (9%)  |
| ||||||||||||||||||||||||||||||||||||
| OCTINOXATE (OCTYL METHOXYCINNAMATE) (7.5%)  |
| ||||||||||||||||||||||||||||||||||||
| NANO TITANIUM DIOXIDE (3.24%)  |
| ||||||||||||||||||||||||||||||||||||
Note to manufacturers: We have assumed a typical particle size for the mineral(s) in your product based on typical industry use. We welcome specific data from manufacturers if actual particle size is different.
Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Miscellaneous, Multiple, additive exposure sources, Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Note from EWG: Unlike many other kinds of personal care products, sunscreen can provide health benefits, protecting against the sun's cancer-causing UV radiation. More than one million cases of skin cancer are diagnosed in the U.S. every year. Health officials recommend wearing sunscreen as one of many important steps to minimize skin cancer risk. (more sun safety tips)
Ingredients from packaging: Active Ingredients: Octocrylene 9%, Octinoxate 7.5%, Titanium Dioxide 3.24%. Inactive Ingredients: Water Cyclomethicone, Isohexadecane, Butylene Glycol, Cyclopentasiloxane, Potassium Cetyl Phosphate, VP/Eicosene Copolymer, C14-22 Alcohols, Aloe Barbadensis Leaf Juice, Mannitol, Diphenyl Dimethicone, Fragrance, Aluminum Hydroxide, C12-20 Alkyl Glucoside, Stearic Acid, Glycerin, Acrylates C10-30 Alkyl Acrylate Crosspolymer, Tromethamine, Tocopheryl Acetate, Disodium EDTA, Xanthan Gum, Cyclodextrin, Pisum Sativum (Pea) Extract, Cassia Alata Leaf Extract, Yeast Extract, Dextrin, Hydrolyzed Adansonia Digitata Extract, Olea Europaea (Olive) Leaf Extract, Platanus Occidentalis Bark Extract, Citric Acid, Phenoxyethanol, Potassium Sorbate, Sodium Benzoate, BHT
Directions from packaging: -Apply as needed, anytime before and during sun exposure
| score | data gap | concerns | |
| NANO TITANIUM DIOXIDE (Active Ingredient) | 2 | 87% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| FRAGRANCE | 8 | 100% | Neurotoxicity, Allergies/immunotoxicity, Miscellaneous |
| OCTINOXATE (OCTYL METHOXYCINNAMATE) (Active Ingredient) | 8 | 65% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Persistence and bioaccumulation, Enhanced skin absorption, Biochemical or cellular level changes |
| BHT | 6 | 61% | Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| ALUMINUM HYDROXIDE | 4 | 86% | Developmental/reproductive toxicity, Neurotoxicity, Organ system toxicity (non-reproductive) |
| TOCOPHERYL ACETATE | 4 | 81% | Allergies/immunotoxicity, Contamination concerns (HYDROQUINONE) |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| DISODIUM EDTA | 3 | 78% | Neurotoxicity, Organ system toxicity (non-reproductive), Enhanced skin absorption |
| CITRIC ACID | 3 | 72% | Violations, restrictions & warnings, Organ system toxicity (non-reproductive) |
| OCTOCRYLENE (Active Ingredient) | 3 | 71% | Violations, restrictions & warnings, Biochemical or cellular level changes |
| CYCLODEXTRIN | 2 | 84% | Multiple, additive exposure sources |
| CYCLOMETHICONE | 2 | 83% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive) |
| GLYCERIN | 2 | 74% | Organ system toxicity (non-reproductive), Occupational hazards |
| STEARIC ACID | 2 | 74% | Neurotoxicity, Irritation (skin, eyes, or lungs) |
| SODIUM BENZOATE | 2 | 69% | Organ system toxicity (non-reproductive) |
| DIPHENYL DIMETHICONE | 1 | 94% | none identified |
| ISOHEXADECANE | 0 | 94% | none identified |
| MANNITOL | 1 | 92% | none identified |
| YEAST EXTRACT | 1 | 90% | none identified |
| TROMETHAMINE | 1 | 87% | none identified |
| POTASSIUM SORBATE | 1 | 85% | none identified |
| BUTYLENE GLYCOL | 1 | 79% | Irritation (skin, eyes, or lungs) |
| ALOE BARBADENSIS (ALOE VERA) GEL ALOE BARBADENSIS LEAF JUICE | 1 | 72% | none identified |
| ACRYLATES/ C10-30 ALKYL ACRYLATE CROSSPOLYMER | 0 | 100% | none identified |
| HYDROLYZED ADANSONIA DIGITATA EXTRACT | 0 | 100% | none identified |
| OLEA EUROPAEA (OLIVE) LEAF EXTRACT | 0 | 100% | none identified |
| POTASSIUM CETYL PHOSPHATE | 0 | 100% | none identified |
| C12-20 ALKYL GLUCOSIDE | 0 | 100% | none identified |
| C14-22 ALCOHOLS | 0 | 100% | none identified |
| CASSIA ALATA LEAF EXTRACT | 0 | 100% | none identified |
| PISUM SATIVUM (PEA) EXTRACT | 0 | 100% | none identified |
| PLATANUS OCCIDENTALIS BARK EXTRACT | 0 | 100% | none identified |
| DEXTRIN | 0 | 94% | none identified |
| VP/ EICOSENE COPOLYMER | 0 | 94% | none identified |
| XANTHAN GUM | 0 | 94% | none identified |
| WATER | 0 | 0% | innocuous |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL | |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more in vitro tests on mammalian cells show positive mutation results | NANO TITANIUM DIOXIDE | |
| One or more in vitro tests on mammalian cells show positive mutation results | TOCOPHERYL ACETATE, SODIUM BENZOATE, POTASSIUM SORBATE, MANNITOL, GLYCERIN, DISODIUM EDTA | |
| Not likely to be carcinogenic in humans | STEARIC ACID | |
| Cancer - not classifiable/not likely to be human carcinogen | BHT |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | SODIUM BENZOATE, DISODIUM EDTA, BUTYLENE GLYCOL, CYCLODEXTRIN, BHT | |
| One or more animal studies show reproductive effects at moderate doses | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show reproductive effects at moderate doses | GLYCERIN, | |
| One or more animal studies show any effects at moderate doses | ALOE BARBADENSIS (ALOE VERA) GEL | |
| Human nervous system toxicant - moderate evidence | ALUMINUM HYDROXIDE |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | SODIUM BENZOATE, ALOE BARBADENSIS (ALOE VERA) GEL | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | CITRIC ACID | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in some types of cosmetics (concentration limit) | products for use around the eyes; products for use on the lips | OCTINOXATE (OCTYL METHOXYCINNAMATE) |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in cosmetics (concentration limit) | PHENOXYETHANOL, OCTOCRYLENE |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | POTASSIUM SORBATE, YEAST EXTRACT, BUTYLENE GLYCOL, GLYCERIN | |
| One or more animal studies show brain and nervous system effects at low doses | DISODIUM EDTA | |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE | |
| One or more animal studies show brain and nervous system effects at moderate doses | PHENOXYETHANOL, SODIUM BENZOATE, TROMETHAMINE | |
| One or more animal studies show brain and nervous system effects at low doses | BHT | |
| One or more animal studies show brain and nervous system effects at very low doses | STEARIC ACID | |
| Strong evidence of human neurotoxicity | ALUMINUM HYDROXIDE | |
| Moderate evidence of human neurotoxicity | FRAGRANCE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | GLYCERIN, DISODIUM EDTA, BHT, BUTYLENE GLYCOL | |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE | |
| Human any disruptor - strong evidence | OCTINOXATE (OCTYL METHOXYCINNAMATE) |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| respiratory - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | NANO TITANIUM DIOXIDE | |
| Human skin toxicant - strong evidence | TOCOPHERYL ACETATE | |
| One or more human case studies show possible photoallergic effects | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| Known human immune system toxicant | FRAGRANCE, BHT |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | NANO TITANIUM DIOXIDE, ALUMINUM HYDROXIDE | |
| Ingredient is suspected or measured to accumulate in people | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Found to be persistent and bioaccumulative in wildlife | OCTOCRYLENE | |
| Persistent, bioaccumulative in wildlife | CYCLOPENTASILOXANE, CYCLOMETHICONE |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show sense organ effects at high doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | YEAST EXTRACT |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | OCTOCRYLENE, STEARIC ACID | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | DIPHENYL DIMETHICONE, CYCLOMETHICONE, CYCLOPENTASILOXANE |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | TROMETHAMINE, | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | BUTYLENE GLYCOL |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | TOCOPHERYL ACETATE, POTASSIUM SORBATE, CYCLODEXTRIN, ALOE BARBADENSIS (ALOE VERA) GEL | |
| One or more animal studies show broad systemic effects at low doses | SODIUM BENZOATE, DISODIUM EDTA, ALUMINUM HYDROXIDE, BHT | |
| One or more animal studies show sense organ effects at very low doses | products for use around the eyes, mouth, or lips | PHENOXYETHANOL, CITRIC ACID |
| One or more animal studies show kidney or renal system effects at very low doses | GLYCERIN, NANO TITANIUM DIOXIDE |
*This table includes all possible miscellaneous concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Ingredient not fully labeled - identity unknown | FRAGRANCE |
*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Designated as safe for general or specific, limited use in food | NANO TITANIUM DIOXIDE, YEAST EXTRACT, TOCOPHERYL ACETATE, XANTHAN GUM, STEARIC ACID, SODIUM BENZOATE, POTASSIUM SORBATE, MANNITOL, GLYCERIN, DISODIUM EDTA, DEXTRIN, CITRIC ACID, BUTYLENE GLYCOL, BHT, ALUMINUM HYDROXIDE, ALOE BARBADENSIS (ALOE VERA) GEL | |
| Used in food or as an additive with limited or no toxicity information available | CYCLODEXTRIN |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Suspected to be an environmental toxin | CYCLOMETHICONE | |
| Not suspected to be an environmental toxin | ALUMINUM HYDROXIDE | |
| Wildlife and environmental toxicity | OCTOCRYLENE, OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Wildlife and environmental toxicity | NANO TITANIUM DIOXIDE |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at high doses | SODIUM BENZOATE, CYCLODEXTRIN | |
| One or more animal studies show skin irritation at moderate doses | GLYCERIN, CYCLOPENTASILOXANE, CYCLOMETHICONE, CITRIC ACID | |
| One or more animal studies show skin irritation at low doses | STEARIC ACID, BHT, | |
| One or more animal studies show significant but moderate pulmonary irritation at low doses | NANO TITANIUM DIOXIDE | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | BUTYLENE GLYCOL |
| Classified as irritant | PHENOXYETHANOL |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | TOCOPHERYL ACETATE | |
| Missing safety data noted by cosmetic industry review | ALOE BARBADENSIS (ALOE VERA) GEL | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | STEARIC ACID, DISODIUM EDTA, PHENOXYETHANOL, POTASSIUM SORBATE, CYCLOMETHICONE, BUTYLENE GLYCOL | |
| Not assessed for safety in cosmetics by industry panel | NANO TITANIUM DIOXIDE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | BHT | |
| Not assessed for safety in cosmetics by industry panel | PLATANUS OCCIDENTALIS BARK EXTRACT, CASSIA ALATA LEAF EXTRACT, PISUM SATIVUM (PEA) EXTRACT, C14-22 ALCOHOLS, C12-20 ALKYL GLUCOSIDE, YEAST EXTRACT, XANTHAN GUM, TROMETHAMINE, VP/ EICOSENE COPOLYMER, POTASSIUM CETYL PHOSPHATE, OLEA EUROPAEA (OLIVE) LEAF EXTRACT, OCTOCRYLENE, MANNITOL, ISOHEXADECANE, HYDROLYZED ADANSONIA DIGITATA EXTRACT, GLYCERIN, FRAGRANCE, DIPHENYL DIMETHICONE, DEXTRIN, CYCLOPENTASILOXANE, CYCLODEXTRIN, CITRIC ACID, ALUMINUM HYDROXIDE, ACRYLATES/ C10-30 ALKYL ACRYLATE CROSSPOLYMER |
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to moderate doses | GLYCERIN | |
| Allowed workplace exposures restricted to low doses | BHT, | |
| Allowed workplace exposures restricted to low doses | NANO TITANIUM DIOXIDE, PHENOXYETHANOL |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show biochemical changes at very low doses where the human health implications are not yet well understood | NANO TITANIUM DIOXIDE | |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | BHT | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CITRIC ACID | |
| Produces excess reactive oxygen species that can interfere with cellular signaling, cause mutations, lead to cell death and may be implicated in cardiovascular disease. | OCTOCRYLENE, OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CYCLOPENTASILOXANE, GLYCERIN, SODIUM BENZOATE, CYCLOMETHICONE |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.